CAS 218795-74-5

Formula: C12H17N3O2S

InChI: InChI=1S/C12H17N3O2S/c1-12(2,3)14-11(18)15-13-7-8-4-5-9(16)6-10(8)17/h4-7,16-17H,1-3H3,(H2,14,15,18)/b13-7+

InChI key: LTFUAYRGVLQXKC-NTUHNPAUSA-N

SMILES: CC(C)(C)NC(=S)N/N=C/C1=C(C=C(C=C1)O)O

IMM-01

CAS: 218795-74-5

Formula: C₁₂H₁₇N₃O₂S

Purity: 98%

Molecular weight: 267.3473

Ref: IN-DA00BJY7

IMM-01

CAS: 218795-74-5

IMM-01

Formula: C₁₂H₁₇N₃O₂S

Purity: ≥98%

Molecular weight: 267.35

Ref: 54-BUP12305

IMM-01

CAS: 218795-74-5

IMM-01 is a novel class of small-molecule agonists of the mammalian Diaphanous (mDia)-related formins, which act downstream of Rho GTPases to assemble actin

Formula: C₁₂H₁₇N₃O₂S

Purity: 98.87%

Color and Shape: Solid

Molecular weight: 267.35

Ref: TM-T25529

IMM-01

CAS: 218795-74-5

N-(tert-Butyl)-2-(2,4-dihydroxybenzylidene)hydrazine-1-carbothioamide

Formula: C₁₂H₁₇N₃O₂S

Purity: 99%

Molecular weight: 267.35

Ref: IN-DG01391886

IMM-01

CAS: 218795-74-5

IMM-01 is a molecule that has been shown to stabilize actin filaments and prevent the disruption of cellular cytoskeletal structures. It has been shown to inhibit tumor growth in xenograft tumor models and to elicit an antibody response in mice when used as an immunization. IMM-01 is also able to induce cytotoxic T cells and natural killer cells, which may be due to its ability to stabilize actin filaments.
IMM-01 is currently being investigated for potential use in cancer therapy and industrial processes, such as the production of antibodies.

Formula: C₁₂H₁₇N₃O₂S

Purity: Min. 95%

Molecular weight: 267.35 g/mol

Ref: 3D-TIA79574